Estimating survival time of patients with glioblastoma multiforme and characterization of the identified microRNA signatures

BACKGROUND: Though glioblastoma multiforme (GBM) is the most frequently occurring brain malignancy in adults, clinical treatment still faces challenges due to poor prognoses and tumor relapses. Recently, microRNAs (miRNAs) have been extensively used with the aim of developing accurate molecular ther...

Descripción completa

Detalles Bibliográficos
Autores principales: Yerukala Sathipati, Srinivasulu, Huang, Hui-Ling, Ho, Shinn-Ying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260001/
https://www.ncbi.nlm.nih.gov/pubmed/28155650
http://dx.doi.org/10.1186/s12864-016-3321-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5260001/
https://www.ncbi.nlm.nih.gov/pubmed/28155650
http://dx.doi.org/10.1186/s12864-016-3321-y

Ejemplares similares